Tabla de Contenidos:
  • Cover
  • Title
  • Copyright
  • End User License Agreement
  • Contents
  • Preface
  • List of Contributors
  • Infections in Pregnancy: Maternal and Fetal Risks
  • Janaína Crispim Freitas, Diana Gonçalves Dantas, Jaline Pessoa Cavalcante, Júlia Alencar de Medeiros, Juliana Davim Ferreira Gomes and Ricardo Ney Cobucci*
  • BACKGROUND
  • VIRAL INFECTIONS
  • Rubella
  • Cytomegalovirus
  • Herpes Simplex Virus
  • Varicella Zoster Virus
  • Parvovirus B19
  • Influenza
  • Zika
  • Human Immunodeficiency Virus
  • BACTERIAL INFECTIONS
  • Syphilis
  • Group B Streptococcus
  • OTHER INFECTIONS
  • Toxoplasmosis
  • CONCLUSION
  • CONSENT FOR PUBLICATION
  • CONFLICT OF INTEREST
  • ACKNOWLEDGEMENTS
  • REFERENCES
  • Pharmacodynamics and Pharmacokinetics of Anti-Infective Agents in Pregnant Women
  • Neidmar da Mata1,*, Letícia Jales1, Ada Isa Custódio1, Mayara Maria Sales Monteiro2, Wenddy de Lima Cavalcanti Lacerda2 and Raniere da Mata Moura1
  • BACKGROUND
  • PHARMACOLOGICAL CONSIDERATIONS AND PHYSIOLOGICAL CHANGES DURING PREGNANCY
  • Pharmacokinetics and Pharmacodynamics
  • Drug Absorption
  • Drug Distribution
  • Drug Metabolism
  • Elimination of Drugs
  • CHANGES IN THE URINARY TRACT DURING PREGNANCY
  • CLASSIFICATION OF USED DRUGS IN PREGNANCY
  • Classification According to The Categories of Risk of Drugs in Pregnancy
  • ANTIBIOTICS AND OTHER ANTI-INFECTIOUS AGENTS IN PREGNANCY
  • Betalactam and Related Antibiotics
  • Penicillins
  • Cephalosporins
  • Macrolides
  • Nitrofurans
  • Aminoglycosides
  • Lincosamides
  • Clindamycin
  • Quinolones
  • Antifungals with Application in Pregnancy
  • Metronidazole
  • Clotrimazole
  • Miconazole
  • Antivirals
  • Acyclovir
  • Penciclovir
  • Trichloroacetic Acid (TCA)
  • Zidovudine/Lamivudine/Nevirapine
  • CONCLUSIONS
  • CONSENT FOR PUBLICATION
  • CONFLICT OF INTEREST
  • ACKNOWLEDGEMENTS
  • REFERENCES
  • Classification and Safety of Anti-Infective Agents During Pregnancy
  • Jaline de Melo Pessoa Cavalcante1, Fernanda Coêlho Paiva1, Janaína Crispim Freitas2, Diana Gonçalves Dantas1, Luana Paiva Souza1 and Ricardo Ney Cobucci1
  • BACKGROUND
  • ANTIMICROBIALS
  • Penicillins
  • Cephalosporins
  • Imipenem
  • Vancomycin
  • Tetracyclines
  • Chloramphenicol
  • Aminoglycosides
  • Macrolide
  • Sulphonamides
  • Quinolones
  • Lincosamides
  • Rifampicin
  • Others
  • Metronidazole
  • Nitrofurantoin
  • Phosphomycin
  • ANTIFUNGALS
  • ANTIVIRAL AGENTS
  • Herpesviridae
  • Antiretrovirals
  • Anti-influenza
  • ANTIMALARIAL AGENTS
  • ANTHELMINTIC AGENTS
  • Ivermectin
  • Benzimidazole (BZs)
  • Praziquantel (FDA Category B)
  • CONCLUSION
  • CONSENT FOR PUBLICATION
  • CONFLICT OF INTEREST
  • ACKNOWLEDGEMENTS
  • REFERENCES
  • Treatment of Urinary Tract Infections in Pregnancy
  • Ayane Cristine Alves Sarmento, Antônio Carlos Queiroz de Aquino, Michelly Nóbrega Monteiro and Iaponira da Silva Figueiredo Vidal*
  • BACKGROUND
  • PATHOGENESIS
  • RISK FACTORS
  • MICROBIOLOGY
  • CLASSIFICATION OF UTIS
  • Asymptomatic Bacteriuria
  • Acute Cystitis